FOLD FY 2019 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$182M+99.7% YoY

Gross Profit

$160M87.9% margin

Operating Income

-$304M-166.8% margin

Net Income

-$356M-195.6% margin

EPS (Diluted)

$-1.48

Cash Flow

Operating Cash Flow

-$250M

Free Cash Flow

-$270M

Stock-Based Comp.

$44M

Balance Sheet

Total Assets

$850M

Total Liabilities

$374M

Stockholders' Equity

$476M

Cash & Equivalents

$143M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$182M	$91M	+99.7%
Gross Profit	$160M	$77M	+108.6%
Operating Income	-$304M	-$329M	+7.5%
Net Income	-$356M	-$349M	-2.1%